Correction for Evans et al., Informing antibiotic treatment decisions: Evaluating rapid molecular diagnostics to identify susceptibility and resistance to carbapenems against acinetobacter spp. in PRIMERS III (Journal of Clinical Microbiology (2017) 55:1 (134-144) DOI: 10.1128/JCM.01524-16)

Antibacterial Resistance Leadership Group (ARLG)

doi:10.1128/JCM.00525-17

Correction for Evans et al., Informing antibiotic treatment decisions: Evaluating rapid molecular diagnostics to identify susceptibility and resistance to carbapenems against acinetobacter spp. in PRIMERS III (Journal of Clinical Microbiology (2017) 55:1 (134-144) DOI: 10.1128/JCM.01524-16)

Antibacterial Resistance Leadership Group (ARLG)

Center for Discovery and Innovation

Hackensack Meridian School of Medicine

Research output: Contribution to journal › Comment/debate

Abstract

Volume 55, no. 1, p. 134-144, 2017, https://doi.org/10.1128/JCM.01524-16. Table S1 in the supplemental material: Isolates PR-369 and PR-469 were mislabeled, and a column containing an alternate list of isolate names (ARLG IDs) was inadvertently omitted. Revised supplemental material is posted at http://jcm.asm.org/content/55/1/134/suppl/DCSupplemental.

Original language	English
Pages (from-to)	1970
Number of pages	1
Journal	Journal of Clinical Microbiology
Volume	55
Issue number	6
DOIs	https://doi.org/10.1128/JCM.00525-17
State	Published - Jun 2017

ASJC Scopus subject areas

Microbiology (medical)

Access to Document

10.1128/JCM.00525-17

Fingerprint

Dive into the research topics of 'Correction for Evans et al., Informing antibiotic treatment decisions: Evaluating rapid molecular diagnostics to identify susceptibility and resistance to carbapenems against acinetobacter spp. in PRIMERS III (Journal of Clinical Microbiology (2017) 55:1 (134-144) DOI: 10.1128/JCM.01524-16)'. Together they form a unique fingerprint.

Cite this

Antibacterial Resistance Leadership Group (ARLG) (2017). Correction for Evans et al., Informing antibiotic treatment decisions: Evaluating rapid molecular diagnostics to identify susceptibility and resistance to carbapenems against acinetobacter spp. in PRIMERS III (Journal of Clinical Microbiology (2017) 55:1 (134-144) DOI: 10.1128/JCM.01524-16). Journal of Clinical Microbiology, 55(6), 1970. https://doi.org/10.1128/JCM.00525-17

Antibacterial Resistance Leadership Group (ARLG). / Correction for Evans et al., Informing antibiotic treatment decisions : Evaluating rapid molecular diagnostics to identify susceptibility and resistance to carbapenems against acinetobacter spp. in PRIMERS III (Journal of Clinical Microbiology (2017) 55:1 (134-144) DOI: 10.1128/JCM.01524-16). In: Journal of Clinical Microbiology. 2017 ; Vol. 55, No. 6. pp. 1970.

@article{c6f15b78ee124441be6086d08d4b8999,

title = "Correction for Evans et al., Informing antibiotic treatment decisions: Evaluating rapid molecular diagnostics to identify susceptibility and resistance to carbapenems against acinetobacter spp. in PRIMERS III (Journal of Clinical Microbiology (2017) 55:1 (134-144) DOI: 10.1128/JCM.01524-16)",

abstract = "Volume 55, no. 1, p. 134-144, 2017, https://doi.org/10.1128/JCM.01524-16. Table S1 in the supplemental material: Isolates PR-369 and PR-469 were mislabeled, and a column containing an alternate list of isolate names (ARLG IDs) was inadvertently omitted. Revised supplemental material is posted at http://jcm.asm.org/content/55/1/134/suppl/DCSupplemental.",

author = "\{Antibacterial Resistance Leadership Group (ARLG)\} and Evans, \{Scott R.\} and Hujer, \{Andrea M.\} and Hongyu Jiang and Hill, \{Carol B.\} and Hujer, \{Kristine M.\} and Mediavilla, \{Jose R.\} and Claudia Manca and Tran, \{Thuy Tien T.\} and Domitrovic, \{T. Nicholas\} and Higgins, \{Paul G.\} and Harald Seifert and Kreiswirth, \{Barry N.\} and Robin Patel and Jacobs, \{Michael R.\} and Liang Chen and Rangarajan Sampath and Thomas Hall and Christine Marzan and Fowler, \{Vance G.\} and Chambers, \{Henry F.\} and Bonomo, \{Robert A.\}",

year = "2017",

month = jun,

doi = "10.1128/JCM.00525-17",

language = "English",

volume = "55",

pages = "1970",

journal = "Journal of Clinical Microbiology",

issn = "0095-1137",

publisher = "American Society for Microbiology",

number = "6",

}

Antibacterial Resistance Leadership Group (ARLG) 2017, 'Correction for Evans et al., Informing antibiotic treatment decisions: Evaluating rapid molecular diagnostics to identify susceptibility and resistance to carbapenems against acinetobacter spp. in PRIMERS III (Journal of Clinical Microbiology (2017) 55:1 (134-144) DOI: 10.1128/JCM.01524-16)', Journal of Clinical Microbiology, vol. 55, no. 6, pp. 1970. https://doi.org/10.1128/JCM.00525-17

Correction for Evans et al., Informing antibiotic treatment decisions: Evaluating rapid molecular diagnostics to identify susceptibility and resistance to carbapenems against acinetobacter spp. in PRIMERS III (Journal of Clinical Microbiology (2017) 55:1 (134-144) DOI: 10.1128/JCM.01524-16). / Antibacterial Resistance Leadership Group (ARLG).
In: Journal of Clinical Microbiology, Vol. 55, No. 6, 06.2017, p. 1970.

Research output: Contribution to journal › Comment/debate

TY - JOUR

T1 - Correction for Evans et al., Informing antibiotic treatment decisions

T2 - Evaluating rapid molecular diagnostics to identify susceptibility and resistance to carbapenems against acinetobacter spp. in PRIMERS III (Journal of Clinical Microbiology (2017) 55:1 (134-144) DOI: 10.1128/JCM.01524-16)

AU - Antibacterial Resistance Leadership Group (ARLG)

AU - Evans, Scott R.

AU - Hujer, Andrea M.

AU - Jiang, Hongyu

AU - Hill, Carol B.

AU - Hujer, Kristine M.

AU - Mediavilla, Jose R.

AU - Manca, Claudia

AU - Tran, Thuy Tien T.

AU - Domitrovic, T. Nicholas

AU - Higgins, Paul G.

AU - Seifert, Harald

AU - Kreiswirth, Barry N.

AU - Patel, Robin

AU - Jacobs, Michael R.

AU - Chen, Liang

AU - Sampath, Rangarajan

AU - Hall, Thomas

AU - Marzan, Christine

AU - Fowler, Vance G.

AU - Chambers, Henry F.

AU - Bonomo, Robert A.

PY - 2017/6

Y1 - 2017/6

N2 - Volume 55, no. 1, p. 134-144, 2017, https://doi.org/10.1128/JCM.01524-16. Table S1 in the supplemental material: Isolates PR-369 and PR-469 were mislabeled, and a column containing an alternate list of isolate names (ARLG IDs) was inadvertently omitted. Revised supplemental material is posted at http://jcm.asm.org/content/55/1/134/suppl/DCSupplemental.

AB - Volume 55, no. 1, p. 134-144, 2017, https://doi.org/10.1128/JCM.01524-16. Table S1 in the supplemental material: Isolates PR-369 and PR-469 were mislabeled, and a column containing an alternate list of isolate names (ARLG IDs) was inadvertently omitted. Revised supplemental material is posted at http://jcm.asm.org/content/55/1/134/suppl/DCSupplemental.

UR - https://www.scopus.com/pages/publications/85019597813

U2 - 10.1128/JCM.00525-17

DO - 10.1128/JCM.00525-17

M3 - Comment/debate

C2 - 28536161

SN - 0095-1137

VL - 55

SP - 1970

JO - Journal of Clinical Microbiology

JF - Journal of Clinical Microbiology

IS - 6

ER -

Antibacterial Resistance Leadership Group (ARLG). Correction for Evans et al., Informing antibiotic treatment decisions: Evaluating rapid molecular diagnostics to identify susceptibility and resistance to carbapenems against acinetobacter spp. in PRIMERS III (Journal of Clinical Microbiology (2017) 55:1 (134-144) DOI: 10.1128/JCM.01524-16). Journal of Clinical Microbiology. 2017 Jun;55(6):1970. doi: 10.1128/JCM.00525-17

Correction for Evans et al., Informing antibiotic treatment decisions: Evaluating rapid molecular diagnostics to identify susceptibility and resistance to carbapenems against acinetobacter spp. in PRIMERS III (Journal of Clinical Microbiology (2017) 55:1 (134-144) DOI: 10.1128/JCM.01524-16)

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this